[go: up one dir, main page]

DK658387A - Clodronat-holdige laegemidler og fremgangsmaade til fremstilling deraf - Google Patents

Clodronat-holdige laegemidler og fremgangsmaade til fremstilling deraf

Info

Publication number
DK658387A
DK658387A DK658387A DK658387A DK658387A DK 658387 A DK658387 A DK 658387A DK 658387 A DK658387 A DK 658387A DK 658387 A DK658387 A DK 658387A DK 658387 A DK658387 A DK 658387A
Authority
DK
Denmark
Prior art keywords
clodronate
lubricant
clodronat
procedures
producing
Prior art date
Application number
DK658387A
Other languages
English (en)
Other versions
DK658387D0 (da
DK174893B1 (da
Inventor
Fritz Demmer
Berthold Stemmle
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DK658387D0 publication Critical patent/DK658387D0/da
Publication of DK658387A publication Critical patent/DK658387A/da
Application granted granted Critical
Publication of DK174893B1 publication Critical patent/DK174893B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DK198706583A 1986-12-20 1987-12-15 Clodronat-holdige præparater og fremgangsmåde til fremstilling deraf DK174893B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3643758 1986-12-20
DE3643758 1986-12-20

Publications (3)

Publication Number Publication Date
DK658387D0 DK658387D0 (da) 1987-12-15
DK658387A true DK658387A (da) 1988-06-21
DK174893B1 DK174893B1 (da) 2004-02-02

Family

ID=6316771

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198706583A DK174893B1 (da) 1986-12-20 1987-12-15 Clodronat-holdige præparater og fremgangsmåde til fremstilling deraf

Country Status (9)

Country Link
US (1) US4859472A (da)
EP (1) EP0275468B1 (da)
AT (1) ATE60711T1 (da)
CA (1) CA1298196C (da)
DE (1) DE3767998D1 (da)
DK (1) DK174893B1 (da)
ES (1) ES2040733T3 (da)
GR (1) GR3001615T3 (da)
HK (1) HK59894A (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0587744B1 (en) * 1991-05-28 2003-07-16 McNEIL-PPC, Inc. Chewable drug-delivery composition
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
CA2162470C (en) * 1993-05-15 1998-06-16 Walter Preis Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
EP0998933A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
RO121891B1 (ro) * 2001-07-04 2008-07-30 Sindan S.R.L. Compoziţie farmaceutică pentru profilaxia şi tratamentul dereglărilor metabolismului calciului şi procedeu de preparare
WO2008128056A1 (en) * 2004-10-08 2008-10-23 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
US7358361B2 (en) * 2004-10-08 2008-04-15 The Board Of Trustees Of The University Of Illinois Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
CA2646334A1 (en) * 2006-03-17 2007-09-27 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods
FR2954320B1 (fr) 2009-12-17 2012-06-15 Cll Pharma Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels
AU2018372762B2 (en) 2017-11-22 2025-08-21 Inbiomotion S.L. Therapeutic treatment of breast cancer based on c-maf status

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1012003B (it) * 1967-12-11 1977-03-10 Procter & Gamble Composizioni veterinarie per inibi re anomalie nella deposizione e mo bilizzazione del fosfato di calcio nei tessuti animali
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
JPS5332111A (en) * 1976-09-07 1978-03-27 Asahi Chem Ind Co Ltd Composition for tablet
GB2043072B (en) * 1979-02-13 1983-11-23 Symphar Sa Diphosphonate compounds
CA1209040A (fr) * 1982-12-21 1986-08-05 Jean Bru Procede de fabrication de granules et comprimes effervescents
US4687662A (en) * 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition

Also Published As

Publication number Publication date
US4859472A (en) 1989-08-22
DK658387D0 (da) 1987-12-15
ATE60711T1 (de) 1991-02-15
DE3767998D1 (de) 1991-03-14
EP0275468A1 (de) 1988-07-27
HK59894A (en) 1994-07-08
GR3001615T3 (en) 1992-11-23
EP0275468B1 (de) 1991-02-06
CA1298196C (en) 1992-03-31
ES2040733T3 (es) 1993-11-01
DK174893B1 (da) 2004-02-02

Similar Documents

Publication Publication Date Title
DK658387A (da) Clodronat-holdige laegemidler og fremgangsmaade til fremstilling deraf
UA18251A (uk) Спосіб одержаhhя таблеток з безперервhим виділеhhям лікарського засобу
ES8603753A1 (es) Procedimiento de fabricacion de comprimidos efervescentes
DE2965725D1 (en) Biodegradable nanoparticles, pharmaceutical compositions containing them and process for their preparation
HU905675D0 (en) Process for the production of dose units, dose units in pressed forms and their use
HUT52752A (en) Fungicides containing as active substance acyl-aminbenzamids and process for production of the active substances
PT73963A (de) Verfahren zur herstellung von schnellzerfallenden arzneimittel--presslingen
YU56987A (en) Process for making controlled pharmaceutic formulations of long time effect in shape of dose unit having single bioaccesness characteristics
HUT47570A (en) Insecticides containing as active substance 3-substituated-1-/chlor-tiasole-5-il-methil/-2-nitroamin-1,3-diaza-cycloalkans and process for production of the active substances
AR015812A1 (es) Proceso para producir una formulacion farmaceutica en pastillas
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
DE3063858D1 (en) Process for the production of a solid form containing a pharmaceutical active agent or a diagnostic
HU910040D0 (en) Process for the production of granulates containing derivatives protected from decomposition in the rumen of ruminants
AT382076B (de) Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
HUT48797A (en) Insecticides, acarycides and nematocides containing as active substance derivatives of aryl-pirrol and process for production of the active substances
AU681980B2 (en) Preparation of fusidic acid tablets
IL47268A (en) Racemic or optically active 4-acyl-1,3,4,5-tetrahydro-2h-1,4-benzo-diazepin-2-ones,process for their preparation and pharmaceutical compositions containing them
HUT47132A (en) Process for producing new 2beta, 16beta-diamono-androstane derivatives and pharmaceutical compositions comprising such compounds
SE8703361D0 (sv) Granulera produkter (iv)
HUT34489A (en) Process for preparing 7-oxo-4-thia-1-aza-bicyclo/3,2,0/hept-2-ene derivatives and pharmaceutical compositions containing thereof as active substances
DE2861570D1 (en) 17 alpha-aryl or 17 alpha-heteroaryl steroids, process for their preparation, their use as medicines and pharmaceutical compositions containing them
EP0433127A3 (en) Sulfated derivative of galactan extracted from klebsiella, process for its preparation, application as medicines and pharmaceutical compositions containing it
SE8401968D0 (sv) A method for preparing well absorptive oral drug dosage forms of medicinal 1,4-dihydropyridine derivatives
ES8300468A1 (es) "un metodo para fabricar una tableta masticable".
HUT53527A (en) Process for production of quickly soluable tabbletts containing as active substance 1,6-dibromee-1,6,-didezoxi-dulates

Legal Events

Date Code Title Description
PUP Patent expired